Foeniculoside I



Compound IDCDAMM02263
Common nameFoeniculoside I
IUPAC name2-[3-hydroxy-5-[6-hydroxy-4-[6-hydroxy-2-(4-hydroxyphenyl)-4-[2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-3-yl]-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-3-yl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Molecular formulaC48H42O14

Experimental data

Retention time15.31
Adduct[M+H]+
Actual mz843.265
Theoretical mz843.264
Error1.21
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.2089

Identifiers and class information

Inchi keySZKVNSODIJRAET-DAFODLJHNA-N
SmilesOC1=CC=C(C=C1)C=CC=2C=C(O)C=C3OC(C4=CC=C(O)C=C4)C(C=5C=C(O)C=C6OC(C7=CC=C(O)C=C7)C(C=8C=C(O)C=C(OC9OC(CO)C(O)C(O)C9O)C8)C65)C32
SuperclassPhenylpropanoids and polyketides
Class2-arylbenzofuran flavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)12
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)16
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)842.851
Computed dipole moment(dipole)5.215
Total solvent accessible surface area (SASA)993.259
Hydrophobic component of SASA (FOSA)140.483
Hydrophilic component of SASA (FISA)390.861
Pie component of the SASA (PISA)461.915
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2155.95
Number of hydrogen bond donors (donorHB)10
Number of hydrogen bond acceptors (accptHB)15.25
Free energy of solvation of dipole (dip^2/V)0.0126147
Index of cohesive interaction in solids (ACxDN^.5/SA)0.048552
Globularity descriptor (glob)0.812571
Predicted polarizability in cubic angstroms (QPpolrz)74.265
Predicted hexadecane/gas partition coefficient (QPlogPC16)25.815
Predicted octanol/gas partition coefficient (QPlogPoct)49.809
Predicted water/gas partition coefficient (QPlogPw)34.048
Predicted octanol/water partition coefficient (QPlogPo/w)2.924
Predicted aqueous solubility (QPlogS)-5.287
Conformation-independent predicted aqueous solubility (CIQPlogS)-11.536
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.768
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1.947
Predicted brain/blood partition coefficient (QPlogBB)-4.347
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.581
Predicted skin permeability, log Kp (QPlogKp)-5.56
PM3 calculated ionization potential (IP(ev))8.479
PM3 calculated electron affinity (EA(eV))0.528
Number of likely metabolic reactions (#metab)16
Prediction of binding to human serum albumin (QPlogKhsa)0.376
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)10.371
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)246.261
Number of nitrogen and oxygen atoms (#NandO)14
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P11387TOP1DNA topoisomerase IT09826SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P60568IL2Interleukin-2T61698SEA
P14679TYRTyrosinaseT97035SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T09826DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P11387TOP1
T09826DI0095Colorectal cancer[ICD-11: 2B91]P11387TOP1
T09826DI0238Lung cancer[ICD-11: 2C25]P11387TOP1
T09826DI0321Ovarian cancer[ICD-11: 2C73]P11387TOP1
T09826DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P11387TOP1
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1

Copyright © 2025